ICON Public (NASDAQ:ICLR) Updates FY25 Earnings Guidance

ICON Public (NASDAQ:ICLR) issued an update on its FY25 earnings guidance on Tuesday morning. The company provided EPS guidance of $13.00-15.00 for the period, compared to the consensus EPS estimate of $14.86. The company issued revenue guidance of $8.05-8.65 billion, compared to the consensus revenue estimate of $8.50 billion. ICON Public also updated its FY 2024 guidance to 13.900-14.100 EPS.

Wall Street Analyst Weigh In

ICLR has been the topic of several recent analyst reports. Evercore ISI reduced their price objective on shares of ICON Public from $360.00 to $350.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Truist Financial reissued a “buy” rating and set a $284.00 price target (down from $295.00) on shares of ICON Public in a research report on Wednesday, December 18th. StockNews.com cut shares of ICON Public from a “buy” rating to a “hold” rating in a research report on Thursday, September 19th. Leerink Partners reissued an “outperform” rating and issued a $255.00 target price (down from $270.00) on shares of ICON Public in a research note on Tuesday, November 19th. Finally, Barclays dropped their price target on ICON Public from $330.00 to $275.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Four equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, ICON Public has an average rating of “Moderate Buy” and a consensus target price of $287.00.

ICON Public Trading Down 0.4 %

NASDAQ ICLR opened at $199.47 on Thursday. ICON Public has a 52 week low of $183.38 and a 52 week high of $347.72. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.34 and a current ratio of 1.34. The stock’s 50 day moving average price is $210.79 and its two-hundred day moving average price is $270.01. The stock has a market capitalization of $16.46 billion, a price-to-earnings ratio of 22.24, a PEG ratio of 1.59 and a beta of 1.20.

ICON Public (NASDAQ:ICLR) last announced its earnings results on Wednesday, October 23rd. The medical research company reported $3.35 EPS for the quarter, missing the consensus estimate of $3.72 by ($0.37). The business had revenue of $2.03 billion for the quarter, compared to analyst estimates of $2.13 billion. ICON Public had a return on equity of 11.91% and a net margin of 9.00%. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.10 EPS. As a group, analysts anticipate that ICON Public will post 13.41 earnings per share for the current fiscal year.

ICON Public Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.